AbbVie (ABBV) Dividends Paid - Common (2013 - 2026)
AbbVie (ABBV) reported Dividends Paid - Common of $3.1 billion for Q1 2026, up 5.5% year-over-year from $2.9 billion in Q1 2025, and up 6.01% on a QoQ basis from $2.9 billion in Q4 2025.
AbbVie (ABBV) has 14 years of Dividends Paid - Common data on file, last reported at $3.1 billion in Q1 2026.
- Quarterly Dividends Paid - Common rose 5.5% year-over-year to $3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.8 billion (up 5.73% YoY) and the FY2025 annual result came in at $11.7 billion, up 5.73% from the prior year.
- Dividends Paid - Common improved to $3.1 billion in Q1 2026 per ABBV's latest filing, from $2.9 billion in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $3.1 billion in Q1 2026 and bottomed at $2.5 billion in Q3 2022.
- The 5-year median for Dividends Paid - Common is $2.8 billion (2024), against an average of $2.7 billion.
- The widest annual swing landed in 2022, when Dividends Paid - Common increased 8.79%; it then grew 4.17% in 2024.
- Tracing ABBV's Dividends Paid - Common over 5 years: stood at $2.5 billion in 2022, then climbed by 4.79% to $2.6 billion in 2023, then grew by 4.8% to $2.8 billion in 2024, then advanced by 5.78% to $2.9 billion in 2025, then grew by 6.01% to $3.1 billion in 2026.
- Per Business Quant, the three latest ABBV Dividends Paid - Common figures stand at $3.1 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.9 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.55 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 3.13 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.09 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 2.11 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.04 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.45 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.28 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.09 Bn |
| Mar 31, 2026 | 3.09 Bn |
| Dec 31, 2025 | 2.91 Bn |
| Dec 31, 2025 | 2.91 Bn |
| Sep 30, 2025 | 2.91 Bn |
| Sep 30, 2025 | 2.91 Bn |
| Jun 30, 2025 | 2.91 Bn |
| Jun 30, 2025 | 2.91 Bn |
| Mar 31, 2025 | 2.93 Bn |
| Mar 31, 2025 | 2.93 Bn |
| Dec 31, 2024 | 2.75 Bn |
| Dec 31, 2024 | 2.75 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Mar 31, 2024 | 2.77 Bn |
| Mar 31, 2024 | 2.77 Bn |
| Dec 31, 2023 | 2.63 Bn |
| Dec 31, 2023 | 2.63 Bn |
| Sep 30, 2023 | 2.63 Bn |
| Sep 30, 2023 | 2.63 Bn |
| Jun 30, 2023 | 2.63 Bn |
| Jun 30, 2023 | 2.63 Bn |
| Mar 31, 2023 | 2.66 Bn |
| Mar 31, 2023 | 2.66 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.50 Bn |
| Sep 30, 2022 | 2.50 Bn |
| Jun 30, 2022 | 2.51 Bn |
| Jun 30, 2022 | 2.51 Bn |
| Mar 31, 2022 | 2.53 Bn |
| Mar 31, 2022 | 2.53 Bn |
| Dec 31, 2021 | 2.31 Bn |
| Dec 31, 2021 | 2.31 Bn |
| Sep 30, 2021 | 2.32 Bn |
| Sep 30, 2021 | 2.32 Bn |
| Jun 30, 2021 | 2.31 Bn |
| Jun 30, 2021 | 2.31 Bn |
| Mar 31, 2021 | 2.32 Bn |
| Mar 31, 2021 | 2.32 Bn |
| Dec 31, 2020 | 2.10 Bn |
| Dec 31, 2020 | 2.10 Bn |
| Sep 30, 2020 | 2.10 Bn |
| Sep 30, 2020 | 2.10 Bn |
| Jun 30, 2020 | 1.75 Bn |
| Jun 30, 2020 | 1.75 Bn |
| Mar 31, 2020 | 1.76 Bn |
| Mar 31, 2020 | 1.76 Bn |
| Dec 31, 2019 | 1.60 Bn |
| Dec 31, 2019 | 1.60 Bn |
| Sep 30, 2019 | 1.59 Bn |
| Sep 30, 2019 | 1.59 Bn |
| Jun 30, 2019 | 1.59 Bn |
| Jun 30, 2019 | 1.59 Bn |
| Mar 31, 2019 | 1.59 Bn |
| Mar 31, 2019 | 1.59 Bn |
| Dec 31, 2018 | 1.45 Bn |
| Dec 31, 2018 | 1.45 Bn |
| Sep 30, 2018 | 1.46 Bn |
| Sep 30, 2018 | 1.46 Bn |
| Jun 30, 2018 | 1.53 Bn |
| Jun 30, 2018 | 1.53 Bn |
| Mar 31, 2018 | 1.14 Bn |
| Mar 31, 2018 | 1.14 Bn |
| Dec 31, 2017 | 1.03 Bn |
| Dec 31, 2017 | 1.03 Bn |
| Sep 30, 2017 | 1.03 Bn |
| Sep 30, 2017 | 1.03 Bn |
| Jun 30, 2017 | 1.02 Bn |
| Jun 30, 2017 | 1.02 Bn |
| Mar 31, 2017 | 1.03 Bn |
| Mar 31, 2017 | 1.03 Bn |
| Dec 31, 2016 | 933.00 Mn |
| Dec 31, 2016 | 933.00 Mn |
| Sep 30, 2016 | 933.00 Mn |
| Sep 30, 2016 | 933.00 Mn |
| Jun 30, 2016 | 927.00 Mn |
| Jun 30, 2016 | 927.00 Mn |
| Mar 31, 2016 | 924.00 Mn |
| Mar 31, 2016 | 924.00 Mn |
| Dec 31, 2015 | 840.00 Mn |
| Dec 31, 2015 | 840.00 Mn |
| Sep 30, 2015 | 850.00 Mn |
| Sep 30, 2015 | 850.00 Mn |
| Jun 30, 2015 | 818.00 Mn |
| Jun 30, 2015 | 818.00 Mn |
| Mar 31, 2015 | 786.00 Mn |
| Mar 31, 2015 | 786.00 Mn |
| Dec 31, 2014 | 674.00 Mn |
| Dec 31, 2014 | 674.00 Mn |
| Sep 30, 2014 | 673.00 Mn |
| Sep 30, 2014 | 673.00 Mn |
| Jun 30, 2014 | 673.00 Mn |
| Jun 30, 2014 | 673.00 Mn |
| Mar 31, 2014 | 641.00 Mn |
| Mar 31, 2014 | 641.00 Mn |
| Dec 31, 2013 | 641.00 Mn |
| Dec 31, 2013 | 641.00 Mn |
| Sep 30, 2013 | 640.00 Mn |
| Sep 30, 2013 | 640.00 Mn |
| Jun 30, 2013 | 638.00 Mn |
| Jun 30, 2013 | 638.00 Mn |
| Mar 31, 2013 | 636.00 Mn |
| Mar 31, 2013 | 636.00 Mn |